Turning Point Therapeutics, Inc. Free Cash Flow 2019-2022 | TPTX
Turning Point Therapeutics, Inc. free cash flow from 2019 to 2022. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
| Turning Point Therapeutics, Inc. Annual Free Cash Flow |
| 2021 |
-156.31 |
| 2020 |
-84.06 |
| 2019 |
-59.43 |
| 2018 |
-23.84 |
| 2017 |
-12.73 |
| Turning Point Therapeutics, Inc. Quarterly Free Cash Flow |
| 2022-06-30 |
-165.60 |
| 2022-03-31 |
-58.78 |
| 2021-12-31 |
-156.31 |
| 2021-09-30 |
-101.77 |
| 2021-06-30 |
-58.94 |
| 2021-03-31 |
-15.79 |
| 2020-12-31 |
-84.06 |
| 2020-09-30 |
-50.22 |
| 2020-06-30 |
-51.88 |
| 2020-03-31 |
-28.32 |
| 2019-12-31 |
-59.43 |
| 2019-09-30 |
-44.67 |
| 2019-06-30 |
-27.33 |
| 2019-03-31 |
-10.22 |
| 2018-12-31 |
-23.84 |
| 2018-09-30 |
-15.90 |
| 2018-06-30 |
-10.69 |
| 2018-03-31 |
-5.50 |
